A premium personal care manufacturer delivering consistent earnings growth through a diversified portfolio of oral care and beauty brands in the US and global markets.
The stock is attractive due to the dramatic improvement in profitability, with net income stabilizing above $200M annually after a prior year loss, signaling a mature and profitable business cycle. Strong free cash flow generation supports shareholder returns through buybacks while providing a buffer against economic downturns in the discretionary consumer goods sector.
Investors should be cautious of the company's substantial accumulated deficit and the risk associated with its large goodwill balance, which could lead to significant non-cash impairments if market conditions deteriorate. The lack of revolver activity suggests limited flexibility in short-term liquidity management compared to peers with revolving credit facilities.
Prestige Consumer Healthcare Inc. is a leading global manufacturer and marketer of premium personal care products, including toothbrushes, floss, and dental hygiene items sold under its Prestige brand across the United States and international markets. The company leverages strategic acquisitions to expand its portfolio while maintaining a focus on high-margin consumer goods with strong distribution networks. Its financial profile reflects a mature business model characterized by significant goodwill from past acquisitions and robust operational cash flow generation.
Management successfully executed a turnaround strategy, evidenced by the jump in net income from -$82.3M in 2023 to $214.6M in 2025, driven by improved operational efficiency and volume growth. Operating cash flow of $251.5M demonstrates strong liquidity generation, allowing for capital expenditures of $8.2M and share repurchases of $51.5M without relying on external financing.
The global personal care industry is shifting towards premiumization and natural ingredients, creating opportunities for established players like Prestige that can command higher price points. However, the sector remains competitive with frequent M&A activity, requiring companies to continuously innovate and manage acquisition integration risks to maintain market share.
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $1.13B | $1.13B | $1.14B |
| Cost of Revenue | $502.4M | $500.9M | $503.3M |
| Gross Profit | $625.3M | $624.4M | $634.5M |
| Operating Expenses | $647.7M | $282.0M | $297.7M |
| Operating Income | $-22.4M | $342.4M | $336.8M |
| G&A | $107.4M | $106.2M | $108.2M |
| Stock-Based Comp | $12.4M | $14.0M | $11.2M |
| D&A | $32.6M | $30.7M | $30.2M |
| Depreciation | $7.7M | $8.2M | $9.7M |
| Amortization | $22.3M | $19.8M | $18.3M |
| Other OpEx | $540.4M | $175.9M | $189.5M |
| Non-Operating Income | $-71.5M | $-66.4M | $-52.6M |
| Interest Expense | — | $5.2M | $1.8M |
| Pre-Tax Income | $-93.9M | $276.0M | $284.2M |
| Income Tax | $-11.6M | $66.7M | $69.6M |
| Continuing Ops | $-82.3M | $209.3M | $214.6M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-82.3M | $209.3M | $214.6M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-82.3M | $209.3M | $214.6M |
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Current Assets | $391.7M | $375.0M | $448.3M |
| Cash & Equivalents | $58.5M | $46.5M | $97.9M |
| Accounts Receivable | $167.0M | $176.8M | $194.3M |
| Inventory | $162.1M | $138.7M | $147.7M |
| Prepaid Expenses | $4.1M | $13.1M | $8.4M |
| Other Current Assets | $0 | $0 | $0 |
| Long-Term Assets | $2.96B | $2.94B | $2.95B |
| PP&E (Net) | $70.4M | $76.5M | $74.5M |
| Intangibles | $2.34B | $2.32B | $2.30B |
| Goodwill | $527.6M | $527.7M | $527.4M |
| Operating Leases | $14.9M | $11.3M | $28.2M |
| Other LT Assets | $7.2M | $7.3M | $28.3M |
| Total Assets | $3.35B | $3.32B | $3.40B |
| Current Liabilities | $160.7M | $117.0M | $106.6M |
| Accounts Payable | $62.7M | $39.0M | $18.9M |
| Current Leases | $6.9M | $4.7M | $6.0M |
| Taxes Payable | $10.6M | $2.6M | $830.0K |
| Other Current Liab | $80.4M | $70.8M | $80.8M |
| Long-Term Liabilities | $1.75B | $1.55B | $1.46B |
| Long-Term Debt | $1.35B | $1.13B | — |
| LT Operating Leases | $9.9M | $7.5M | $22.7M |
| Other LT Liab | $390.3M | $413.0M | $1.44B |
| Total Liabilities | $1.91B | $1.66B | $1.57B |
| Shareholders' Equity | $1.45B | $1.66B | $1.83B |
| Paid-In Capital | $535.4M | $567.4M | $593.4M |
| Retained Earnings | $1.13B | $1.34B | $1.56B |
| AOCI | $-31.6M | $-34.5M | $-37.7M |
| Total L&E | $3.35B | $3.32B | $3.40B |
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net Income (CFO) | $-82.3M | $209.3M | $214.6M |
| Non-Cash Adjustments | $228.9M | $89.3M | $27.5M |
| Working Capital Changes | $83.2M | $-49.7M | $9.5M |
| Cash from Operations | $229.7M | $248.9M | $251.5M |
| Capital Expenditures | $7.8M | $9.6M | $8.2M |
| Cash from Investing | $-11.6M | $-20.1M | $-17.5M |
| Share Buybacks | $50.0M | $25.0M | $51.5M |
| Cash from Financing | $-185.8M | $-241.0M | $-182.1M |
| FX Effect | $-982.0K | $180.0K | $-573.0K |
| Net Change in Cash | $31.3M | $-12.0M | $51.4M |
| Beginning Cash | $27.2M | $58.5M | $46.5M |
| Ending Cash | $58.5M | $46.5M | $97.9M |
The company's revenue is driven primarily by its Prestige brand, which dominates the premium toothbrush and floss categories, alongside other branded consumer health products acquired over time to diversify risk and capture different market segments.
Significant goodwill on the balance sheet ($527.4M) creates potential impairment risks if consumer trends shift or acquisition synergies fail to materialize. The company faces ongoing regulatory scrutiny regarding marketing claims for health benefits and supply chain volatility affecting raw material costs. Additionally, a large retained earnings deficit of $1.56B indicates historical losses that require sustained profitability to reverse.
Prestige Consumer Healthcare benefits from a dominant market position in the high-end oral care sector, strong brand loyalty among affluent consumers, and a scalable manufacturing footprint that supports efficient production of its diverse product lines.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.